New device from Birmingham, UK, to provide early diagnosis of cardiac tamponade

Cardiac tamponade can occur soon after heart surgery and diagnosis is difficult because it can be confused with other causes of heart failure. 1 credit

A company formed by Birmingham cardiothoracic surgeon Mr Hazem Fallouh has been awarded a £500,000 grant from Innovate UK to develop a new device for the early diagnosis of a life-threatening condition caused by the build-up of blood clots in the space around the heart.

Fallouh Healthcare is developing the device to monitor heart patients after surgery, which is when the condition, called cardiac tamponade, typically strikes.

Typically, this happens late at night when the patient is in intensive care, and as the blood clots accumulate, they compress the heart, reducing its ability to pump blood throughout the body.

Around 45,000 patients in the UK undergo heart surgery each year, and it is generally safe. However, cardiac tamponade can occur quickly and diagnosis is difficult because it can be confused with other causes of heart failure.

If missed, cardiac tamponade can result in cardiac arrest that resists CPR and requires immediate opening of the patient’s chest in the uncontrolled environment of the intensive care unit – a procedure that has a fatality rate. (30-70%) and poor outcomes for patients who survive.

Consultant surgeon Mr Fallouh, who has worked in many centers of excellence in the UK, invented the device to provide early diagnosis of tamponade, allowing a planned return to surgery to drain fluid and clots around the heart.

Called PerDeCT (Pericardial Device to Monitor Cardiac Output and Diagnose Tamponade), it is the only device to diagnose cardiac tamponade and provide cardiac monitoring at no additional cost.

In 2021, Dr. Fallouh, who has already commercialized two award-winning inventions in cardiac surgery, received the prestigious Techno-College Innovation Award at the 35th Annual Meeting of the European Society for Cardiothoracic Surgery for PerDeCT, which was up against 11 technologies by panels of expert surgeons, cardiologists and specialists in medical devices and investments.

The device consists of a probe and a balloon, which is placed in the pericardium (the sac around the heart) during initial surgery, and measures cardiac efficiency (cardiac output) as well as predicts the development of tamponade, examining the trend of the relationship between balloon inflation and cardiac efficiency. It can be removed through the skin after the patient has recovered.

Intellectual property in the form of a patent is assigned to Fallouh Healthcare Limited.

Fallouh Healthcare is a start-up whose mission is to provide smart solutions to unmet needs in order to provide safer and more efficient cardiothoracic surgery.

The company has now established itself in Unit 9a short-term medical technology incubator funded by University of Birmingham Companythe Greater Birmingham & Solihull Local Enterprise Growth Hub and the West Midlands Combined Authority to provide flexible, low-cost facilities for medical research, proof of concept and prototyping activity.

The Innovate UK project is being carried out in collaboration with the University Hospitals Birmingham NHS Foundation Trust (UHB) and the University of Sheffield. Funding from Innovate UK will enable Fallouh Healthcare to build a prototype and conduct a usability study at the UHB Queen Elizabeth Hospital site, the Medical Device—Test and Evaluation Center (MD-TEC).

Plus d’information:
For further media inquiries, contact Ruth Ashton, University of Birmingham Enterprise, email:
For commercial information about Fallouh Healthcare, contact Mahesh Uppara, Program Director, email:
Inquiries about Unit 9 residency should be directed to Angie Reynolds, Birmingham Research Park Manager, email:
About Fallouh Healthcare
Fallouh Healthcare was founded by Dr. Hazem Fallouh, MD, PhD, FRCS-CTh, who is the inventor of PerDeCT. A qualified cardiothoracic surgeon, he successfully patented and commercialized two award-winning inventions in cardiac surgery. He is joined by a very competent team of multidisciplinary professionals to ensure efficient delivery of the project.

Provided by University of Birmingham

Citation: New device from Birmingham, UK, to provide early diagnosis of cardiac tamponade (2022, Dec 5) Retrieved Dec 5, 2022 from -birmingham-uk-to-provide-early-diagnosis-for-car.html

This document is subject to copyright. Except for fair use for purposes of private study or research, no part may be reproduced without written permission. The content is provided for information only.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.